Group B Streptococcus Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Condition: GBS DiseaseInterventions: Biological: GBS vaccine; Biological: PlaceboSponsor: Novartis VaccinesRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2014 Category: Research Source Type: clinical trials
Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Condition: GBS DiseaseInterventions: Biological: GBS vaccine; Biological: PlaceboSponsor: Novartis VaccinesRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2014 Category: Research Source Type: clinical trials
Safety and Immunogenicity of a Trivalent Group B Streptococcus Vaccine in Healthy Pregnant Women
Condition: GBS DiseaseInterventions: Biological: GBS vaccine; Biological: PlaceboSponsor: Novartis VaccinesRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2014 Category: Research Source Type: clinical trials
Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.
Condition: Invasive Group B Streptococcus DiseaseIntervention: Sponsors: Novartis Vaccines; NovartisRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2013 Category: Research Source Type: clinical trials
Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.
Condition: Invasive Group B Streptococcus DiseaseIntervention: Sponsors: Novartis Vaccines; NovartisActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 26, 2013 Category: Research Source Type: clinical trials
Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.
Condition: Invasive Group B Streptococcus DiseaseIntervention: Sponsors: Novartis Vaccines; NovartisRecruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2013 Category: Research Source Type: clinical trials
Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.
Condition: Invasive Group B Streptococcus DiseaseIntervention: Sponsors: Novartis Vaccines; NovartisActive, not recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2013 Category: Research Source Type: clinical trials
Feasibility Study Identifying Antibody Levels Associated With Reduced Risk of Invasive Group B Streptococcus Disease in Young Infants.
Condition: Invasive Group B Streptococcus DiseaseIntervention: Sponsor: Novartis VaccinesCompleted - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 25, 2013 Category: Research Source Type: clinical trials
